Lynn Frohnmayer, FARF co-founder, has lost all three daughters to Fanconi anemia. At the 30th FA Scientific Symposium, she spoke about her family's story and three decades of progress in FA research.
People with FA have a 500- to 700-fold increased risk of developing head and neck tumors when compared to the general population. Alternative therapeutic options are desperately needed.
To celebrate FARF’s 30th anniversary, we are asking our community to help design an original, limited edition FARF t-shirt.
More than 250 FA researchers and clinicians gathered in late 2018 to share updates in FA research and clinical care. Here are the key takeaways.
The 30th Symposium featured new and exciting sessions and grant opportunities, inspiring talks by adults with FA, and celebration of progress in FA research and treatments over 30 years.
Learn more about Dr. Smogorzewska of The Rockefeller University.
One awesome way to make an impact this holiday season is to be part of life-changing FA research.